Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Picot, N; Le Mener, V; Rotivel, Y; Schonfeld, C; Cetre, JC; Costy, F; Grillet, JP; Lanta, N; Lang, J
   Booster effect of a new chromatographically purified Vero-cell rabies vaccine (CPRV): immunogenicity and safety of a single or double injection
   TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
   
   N. Picot et al., "Booster effect of a new chromatographically purified Vero-cell rabies vaccine (CPRV): immunogenicity and safety of a single or double injection", T RS TROP M, 95(3), 2001, pp. 342-344
2. Costy, F; Renders, C; Brochier, B; Pastoret, PP; Le Mener, V; Lang, J
   Clinical trials of safety and immunogenicity of inactived and purifies rabies vaccine in healthy subjects
   ANNALES DE MEDECINE VETERINAIRE
   
   F. Costy et al., "Clinical trials of safety and immunogenicity of inactived and purifies rabies vaccine in healthy subjects", ANN MED VET, 144(2), 2000, pp. 65-72
3. Quiambao, BP; Lang, J; Vital, S; Montalban, CG; Le Mener, V; Wood, SC; Miranda, E
   Immunogenicity and effectiveness of post-exposure rabies prophylaxis with a new chromatographically purified Vero-cell rabies vaccine (CPRV): a two-stage randomised clinical trial in the Philippines
   ACTA TROPICA
   
   B.P. Quiambao et al., "Immunogenicity and effectiveness of post-exposure rabies prophylaxis with a new chromatographically purified Vero-cell rabies vaccine (CPRV): a two-stage randomised clinical trial in the Philippines", ACT TROP, 75(1), 2000, pp. 39-52
4. Sabchareon, A; Lang, J; Attanath, P; Sirivichayakul, C; Pengsaa, K; Le Mener, V; Chantavanich, P; Prarinyanuphab, V; Pojjaroen-Anant, C; Nimnual, S; Wood, SC; Riffard, P
   A new vero cell rabies vaccine: Results of a comparative trial with human diploid cell rabies vaccine in children
   CLINICAL INFECTIOUS DISEASES
   
   A. Sabchareon et al., "A new vero cell rabies vaccine: Results of a comparative trial with human diploid cell rabies vaccine in children", CLIN INF D, 29(1), 1999, pp. 141-149
5. Chippaux, JP; Lang, J; Amadi-Eddine, S; Fagot, P; Le Mener, V
   Short report: Treatment of snake envenomations by a new polyvalent antivenom composed of highly purified F(ab ')(2): results of a clinical trial in northern Cameroon
   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
   
   J.P. Chippaux et al., "Short report: Treatment of snake envenomations by a new polyvalent antivenom composed of highly purified F(ab ')(2): results of a clinical trial in northern Cameroon", AM J TROP M, 61(6), 1999, pp. 1017-1018
6. Lang, J; Cetre, JC; Picot, N; Lanta, M; Briantais, P; Vital, S; Le Mener, V; Lutsch, C; Rotivel, Y
   Immunogenicity and safety in adults of a new chromatographically purified Vero-cell rabies vaccine (CPRV): a randomized, double-blind trial with purified Vero-cell rabies vaccine (PVRV)
   BIOLOGICALS
   
   J. Lang et al., "Immunogenicity and safety in adults of a new chromatographically purified Vero-cell rabies vaccine (CPRV): a randomized, double-blind trial with purified Vero-cell rabies vaccine (PVRV)", BIOLOGICALS, 26(4), 1998, pp. 299-308
7. Chippaux, JP; Lang, J; Eddine, SA; Fagot, P; Rage, V; Peyrieux, JC; Le Mener, V
   Clinical safety of a polyvalent F(ab ')(2) equine antivenom in 223 Africansnake envenomations: a field trial in Cameroon
   TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
   
   J.P. Chippaux et al., "Clinical safety of a polyvalent F(ab ')(2) equine antivenom in 223 Africansnake envenomations: a field trial in Cameroon", T RS TROP M, 92(6), 1998, pp. 657-662